Firmagon (Degarelix) Intermittent Therapy

Clinical trial NCT01512472 · TERMINATED

Trial details

NCT number: NCT01512472
Sponsor: Canadian Urology Research Consortium
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Prostate Cancer Recurrent

Start date: 2012-01-01
Primary completion: 2018-01-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.